The IMARC Group's latest research report, titled "Oral Proteins and Peptides Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032," offers a comprehensive analysis of the industry, which comprises insights on the oral proteins and peptides market forecast. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global oral proteins and peptides market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.51% during 2024-2032.
Oral Proteins and Peptides Market Overview:
Oral proteins and peptides represent a growing category within the pharmaceutical industry, focused on the development and commercialization of protein and peptide-based therapies administered orally. Unlike traditional methods that typically involve injections, these biomolecules are formulated to withstand the harsh conditions of the gastrointestinal tract and are absorbed into the bloodstream through the intestinal lining. This class of therapeutics includes a variety of hormones, enzymes, and antibodies tailored to treat a wide range of chronic diseases, including diabetes, osteoporosis, and autoimmune disorders. Additionally, the advantages of oral administration are significant, offering greater patient compliance, reduced risk of infections, and improved quality of life due to the non-invasive nature of treatment. Furthermore, these treatments can potentially lead to more consistent therapeutic levels with fewer side effects compared to injectable counterparts.
Get Sample Copy of Report at – https://www.imarcgroup.com/oral-proteins-peptides-market/requestsample
Oral Proteins and Peptides Market Trends:
The global market is experiencing rapid growth, driven by technological advances in drug delivery systems that enhance the bioavailability and stability of these molecules when administered orally. Significant investment in biotechnology research has led to innovative formulations that overcome the digestive challenges traditionally associated with protein and peptide therapies. Along with this, the rising prevalence of chronic diseases globally, coupled with an aging population, is fueling demand for more effective and patient-friendly treatments, further propelling market expansion. In addition, the shift towards personalized medicine is increasing the need for specialized therapies that oral proteins and peptides can provide. Moreover, regulatory support for novel drug delivery systems and the high potential for patent extensions when reformulating existing therapies for oral delivery are also key factors stimulating the growth of this market.
Competitive Landscape with Key Players:
Amryt Pharma Plc
AstraZeneca PLC
Biocon Limited
Novo Nordisk A/S
Oramed Ltd
Proxima Concepts Limited
Key Market Segmentation:
Drug Type Insights:
Linaclotide
Plecanatide
Calcitonin
Insulin
Octreotide
Application Insights:
Gastric and Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
Market Performance
Market Outlook
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Comentarios